Ascendis Pharma A ASND
NASDAQ ASND
$227.87 +0.56 (+0.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Consolidated Net Income (2014 - 2026)

Updated

Ascendis Pharma A (ASND) reported Consolidated Net Income of $240.57 million for the quarter ended Jun 30, 2026, compared with -$43.98 million a year earlier and down 67.3% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Consolidated Net Income (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Consolidated Net Income came in at $867 million; for the year ended Dec 31, 2025, it came in at -$257.64 million.

  • By year, Consolidated Net Income came in at -$409.21 million in the year ended Dec 31, 2024, -$520.79 million in the year ended Dec 31, 2023, -$614.66 million in the year ended Dec 31, 2022 and -$438.8 million in the year ended Dec 31, 2021.
  • Five-year quarterly Consolidated Net Income spans a low of -$211.62 million in the quarter ended Dec 31, 2022 and a high of $736.8 million in the quarter ended Mar 31, 2026.
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $736.8 million (quarter ended Mar 31, 2026), -$39.07 million (quarter ended Dec 31, 2025) and -$71.3 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 5.53 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.62 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.51 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -10.50 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -237.00 Mn
10 Ascendis Pharma A 14.09 Bn 10.33 Bn 362.22 Mn 240.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240.57 Mn
Mar 31, 2026 736.80 Mn
Dec 31, 2025 -39.07 Mn
Sep 30, 2025 -71.30 Mn
Jun 30, 2025 -43.98 Mn
Mar 31, 2025 -99.54 Mn
Dec 31, 2024 -41.11 Mn
Sep 30, 2024 -108.94 Mn
Jun 30, 2024 -117.79 Mn
Mar 31, 2024 -142.35 Mn
Dec 31, 2023 -93.48 Mn
Sep 30, 2023 -176.59 Mn
Jun 30, 2023 -132.23 Mn
Mar 31, 2023 -119.05 Mn
Dec 31, 2022 -211.62 Mn
Sep 30, 2022 -170.35 Mn
Jun 30, 2022 -86.77 Mn
Mar 31, 2022 -140.85 Mn
Dec 31, 2021 -121.33 Mn
Sep 30, 2021 -94.75 Mn
API Access

Ascendis Pharma A Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ASND&period=max&api_key=YOUR_API_KEY